Yven Van Herrewege

Research output

Research output per year 2002 2002 2004 2007 2008 2019 2021 2024 2024

• 22 A1: Web of Science-article
• 1 Letter
• 1 Doctoral dissertation - Doctoral dissertation

Research output per year

Research output per year

Search results

• 2024

  Antimalarial artesunate-mefloquine versus praziquantel in African children with schistosomiasis: an open-label, randomized controlled trial

  Bottieau, E., Mbow, M., Brosius, I., Roucher, C., Gueye, C. T., Mbodj, O. T., Faye, B. T., De Hondt, A., Smekens, B., Arango, D., Burm, C., Tsoumanis, A., Paredis, L., Van Herrewege, Y., Potters, I., Richter, J., Rosanas-Urgell, A., Cissé, B., Mboup, S. & Polman, K., 2024, In: Nature Medicine. 30, p. 130-137

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • Praziquantel 100%
  • Artesunate 88%
  • Mefloquine 88%
  • Antimalarial 75%
  • Child 27%

• Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trial

  Vanbaelen, T., Tsoumanis, A., Florence, E., Van Dijck, C., Veld, D. H. I., Sauvage, AS., Herssens, N., De Baetselier, I., Rotsaert, A., Verhoeven, V., Henrard, S., Van Herrewege, Y., van den Bossche, D., Goffard, JC., Padalko, E., Reyniers, T., Vuylsteke, B., Hayette, MP., Libois, A. & Kenyon, C., 2024, In: Lancet HIV. 11, 4, p. e233-e244 12 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • Neisseria gonorrhoeae 100%
  • Gonorrhea 99%
  • Chlamydia trachomatis 95%
  • Sexual and Gender Minorities 85%
  • Multicenter Studies 72%
• 2023

  Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun® in last-minute travellers: an open-label, single-Centre, randomized controlled pilot trial

  FASTBEPROTECT Research Team, 2023, (E-pub ahead of print) In: Journal of Travel Medicine.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Tick-Borne Encephalitis 100%
  • vaccination 27%
  • Group 20%
  • Tick-Borne Encephalitis Viruses 19%
  • Yellow Fever 19%
  81 Downloads (Pure)
• 2021

  Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial

  Van Dijck, C., Tsoumanis, A., Rotsaert, A., Vuylsteke, B., Van den Bossche, D., Paeleman, E., De Baetselier, I., Brosius, I., Laumen, J., Buyze, J., Wouters, K., Lynen, L., Van Esbroeck, M., Herssens, N., Abdellati, S., Declercq, S., Reyniers, T., Van Herrewege, Y., Florence, E. & Kenyon, C., 2021, In: Lancet Infectious Diseases. 21, 5, p. 657-667 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Sexual and Gender Minorities 100%
  • Cross-Over Studies 88%
  • Placebos 66%
  • Incidence 18%
  • Ludwig's Angina 17%

• Chlorhexidine mouthwash fails to eradicate oropharyngeal gonorrhea in a clinical pilot trial (MoNg)

  Van Dijck, C., Tsoumanis, A., De Hondt, A., Cuylaerts, V., Laumen, J., Van Herrewege, Y., Florence, E., De Baetselier, I. & Kenyon, C., 2021, In: Sexually Transmitted Diseases. 49, 2, p. e38-e41

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Chlorhexidine 100%
  • Neisseria gonorrhoeae 98%
  • Gonorrhea 98%
  • Sexual and Gender Minorities 84%
  • Belgium 40%

• Evaluation of artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (SchistoSAM): protocol of a proof-of-concept, open-label, two-arm, individually-randomised controlled trial

  Roucher, C., Brosius, I., Mbow, M., Faye, B. T., De Hondt, A., Smekens, B., Arango, D., Burm, C., Tsoumanis, A., Paredis, L., van Herrewege, Y., Potters, I., Cisse, B., Mboup, S., Polman, K. & Bottieau, E., 2021, In: BMJ Open. 11, 6, e047147.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Artesunate 100%
  • Mefloquine 99%
  • Child 30%
  • Microscopy 16%
  • DNA 11%
  79 Downloads (Pure)

• Vaccinating children in high-endemic rabies regions: what are we waiting for?

  Soentjens, P., Berens-Riha, N., Van Herrewege, Y., Van Damme, P., Bottieau, E. & Ravinetto, R., 2021, In: BMJ Global Health . 6, 2, 3 p., e004074.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • prophylaxis 100%
  • Child 32%
  • Income 24%
  • low income 11%
  • income 10%
  29 Downloads (Pure)
• 2019

  Comparative immunogenicity and safety trial of 2 different schedules of single-visit intradermal rabies postexposure vaccination

  Soentjens, P., De Koninck, K., Tsoumanis, A., Herssens, N., Van Den Bossche, D., Terryn, S., Van Gucht, S., Van Damme, P., Van Herrewege, Y. & Bottieau, E., 2019, In: Clinical Infectious Diseases. 69, 5, p. 797-804 8 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Chickens 100%
  • Embryonic Structures 84%
  • Injection Site Reaction 71%
  • Compliance 46%
  5 Downloads (Pure)

• Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days

  Soentjens, P., Andries, P., Aerssens, A., Tsoumanis, A., Ravinetto, R., Heuninckx, W., van Loen, H., Brochier, B., Van Gucht, S., Van Damme, P., Van Herrewege, Y. & Bottieau, E., 2019, In: Clinical Infectious Diseases. 68, 4, p. 607-614 8 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Diploidy 100%
  • Injection Site Reaction 42%
  23 Downloads (Pure)

• Time of administration of rabies immunoglobulins and adequacy of antibody response upon post-exposure prophylaxis: a descriptive retrospective study in Belgium

  Soentjens, P., Croughs, M., Burm, C., Declerq, S., Clerinx, J., Maniewski, U., Van Den Broucke, S., Theunissen, C., Huits, R., Brosius, I., Florence, E., Kenyon, C., Van Griensven, J., Van Ierssel, S., Lynen, L., Balliauw, K., Van Gucht, S., Van Esbroeck, M., Vlieghe, E., Bottieau, E., & 1 othersVan Herrewege, Y., 2019, In: Acta Clinica Belgica. 76, 2, p. 91-97 7 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Chiroptera 100%
  • Tropical Medicine 57%
  • Costa Rica 56%
  • Wounds and Injuries 56%
  • Morocco 52%
  91 Downloads (Pure)
• 2009

  In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20)

  Jenabian, MA., Saïdi, H., Charpentier, C., Van Herrewege, Y., Son, JC., Schols, D., Balzarini, J., Vanham, G. & Bélec, L., 2009, In: Journal of Antimicrobial Chemotherapy. 64, 6, p. 1192-1195 4 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2008

  Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays

  Heyndrickx, L., Vermoesen, T., Vereecken, K., Kurth, J., Coppens, S., Aerts, L., Ohagen, A., Van Herrewege, Y., Lewi, P. & Vanham, G., 2008, In: Journal of Virological Methods. 148, 1-2, p. 166-173 8 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor

  Vermeire, K., Brouwers, J., Van Herrewege, Y., Le Grand, R., Vanham, G., Augustijns, P., Bell, TW. & Schols, D., 2008, In: Current HIV Research. 6, 3, p. 246-256 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides

  Van Herrewege, Y., Morellato, L., Descours, A., Aerts, L., Michiels, J., Heyndrickx, L., Martin, L. & Vanham, G., 2008, In: Journal of Antimicrobial Chemotherapy. 61, 4, p. 818-826 9 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection

  Terrazas-Aranda, K., Van Herrewege, Y., Hazuda, D., Lewi, P., Costi, R., Di Santo, R., Cara, A. & Vanham, G., 2008, In: Antimicrobial Agents and Chemotherapy. 52, 7, p. 2544-2554 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2007

  A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides

  Van Herrewege, Y., Michiels, J., Waeytens, A., De Boeck, G., Salden, E., Heyndrickx, L., van den Mooter, G., de Béthune, MP., Andries, K., Lewi, P., Praet, M. & Vanham, G., 2007, In: Antiviral Research. 74, 2, p. 111-124

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

  Balzarini, J., Van Herrewege, Y., Vermeire, K., Vanham, G. & Schols, D., 2007, In: Molecular Pharmacology. 71, 1, p. 3-11

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection

  Terrazas-Aranda, K., Van Herrewege, Y., Lewi, PJ., Van Roey, J. & Vanham, G., 2007, In: Antiviral Chemistry & Chemotherapy. 18, 3, p. 141-151

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2004

  A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides

  Van Herrewege, Y., Vanham, G., Michiels, J., Fransen, K., Kestens, L., Andries, K., Janssen, P. & Lewi, P., 2004, In: Antimicrobial Agents and Chemotherapy. 48, 10, p. 3684-3689

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

  Van Herrewege, Y., Michiels, J., Van Roey, J., Fransen, K., Kestens, L., Balzarini, J., Lewi, P., Vanham, G. & Janssen, P., 2004, In: Antimicrobial Agents and Chemotherapy. 48, 1, p. 337-339

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2002

  Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission

  Van Herrewege, Y., Penne, L., Vereecken, C., Fransen, K., van der Groen, G., Kestens, L., Balzarini, J. & Vanham, G., 2002, In: AIDS Research and Human Retroviruses. 18, 15, p. 1091-1102

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells

  Balzarini, J., Van Herrewege, Y. & Vanham, G., 2002, In: AIDS. 16, p. 2159-2163

  Research output: Contribution to journal › A1: Web of Science-article › peer-review